Overview

Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This extension study is considered to allow patients being treated with EC-MPS to collect further information on the long-term safety of this drug.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Cyclosporine
Cyclosporins
Mycophenolate mofetil
Mycophenolic Acid